Skip to content

ADVANCE® KIMP312LRecalls & reported problems

Microport Orthopedics Inc. · ADVANCE® II MEDIAL PIVOT TIBIAL INSERT SZ 3 LEFT 12mm · Class 2 · Implant

All models of ADVANCE (147)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
2
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI M684KIMP312L1), received between Nov 3, 2020 and Apr 17, 2023 — classified as 2 injuries.

The most frequently reported specific device problem is “Unstable” (2 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Unstable2
  • Naturally Worn1

Patient problems

  • Insufficient Information1
  • No Information1

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • InjuryApr 17, 2023Unstable; Naturally Worn; Unstable; Naturally Worn

    ALLEGEDLY, PATIENT WAS REVISED DUE TO INSTABILITY/WEAR OF POLYETHYLENE COMPONENT. REVISION NJR NUMBER: 5052592. SIDE: L . PRIMARY ASA: P2 - MILD DISEASE NOT INCAPACITATING.

    Patient problems: Insufficient Information

    MAUDE report 16751393 ↗
  • InjuryNov 3, 2020Unstable; Unstable

    ALLEGEDLY, PATIENT WAS REVISED DUE TO INSTABILITY; REVISION NJR NUMBER: (B)(4); SIDE: L; PRIMARY ASA: P1 - FIT AND HEALTHY; MHRA REFERENCE NO:(B)(4).

    Patient problems: No Information

    MAUDE report 10777239 ↗

Other Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Cemented, Polymer/Metal/Polymer devices

All Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Cemented, Polymer/Metal/Polymer devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page